Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
10 Results Found
Executive Summary: Tariffs and Their Impact on the U.S. Health Care Supply Chain
The U.S. health care system relies heavily on a global supply chain for pharmaceuticals and medical devices.
AHA Urges Administration to Grant Exceptions for Current and Proposed Tariffs for Medications and Medical Supplies
The AHA late yesterday told the administration that its current and proposed tariffs on Canada, Mexico and China may jeopardize the availability of vital medications and essential health care devices.
AHA Comments on the Proposed Change to Section 301 Tariffs for Goods Made in China – 90183100
June 28, 2024 The Honorable Katherine TaiU.S. Trade Representative600 17th Street NWWashington, DC 20508
Tariff Implications for American Health Care
A series of tariffs recently implemented could have significant implications for health care.
AHA Urges Administration to Grant Exceptions for Tariffs for Medications and Medical Supplies
The AHA asks President Trump to consider granting exceptions to the current and proposed tariffs for medical devices and pharmaceuticals made in Mexico, Canada and China that are essential to the provision of safe, effective care in America's hospitals, clinics, and other settings.
AHA Comments on Commerce Department Investigation of Pharmaceutical Imports
AHA comments on the Department of Commerce’s request for public comment on its Section 232 national security investigation on pharmaceutical and pharmaceutical ingredient imports.
AHA Responds to Commerce Department Investigation of Critical Minerals
AHA comments on the Department of Commerce’s request for public comment on its Section 232 national security investigation on processed critical minerals and derivative products.
Trump Administration Unveils New Tariff Plan
The White House April 2 issued an executive order implementing a comprehensive new tariff plan.
Chair File: Leadership Dialogue — Tariffs and Health Care with Brian Pomper and Akin Demehin
In this Leadership Dialogue, I am joined by Brian Pomper, a partner specializing in international trade policy at Akin Gump Strauss Hauer & Feld, and Akin Demehin, vice president of quality and safety policy at the AHA. We discuss tariffs and their potential implications on the health care supply chain.
Tariffs, Trade and the Health Care Supply Chain: What Leaders Need to Know
Tina Freese Decker talks with Brian Pomper about the past and present state of U.S. tariff policy, how tariffs could impact hospital and health system operations, and ways health care leaders can engage as policy advocates.